Cepheid and American Lung Association Partner for Tuberculosis Awareness in U.S.

SUNNYVALE, CALIF. (July 23, 2013)

Cepheid (Nasdaq: CPHD) and the American Lung Association (www.Lung.org) today announced a partnership to promote tuberculosis-related awareness in the U.S. and the need for improved TB (tuberculosis) diagnostics. Details of the planned program will be announced at the American Association of Clinical Chemistry and Clinical Lab Expo show in Houston, Texas. The live announcement will take place at 10am on July 30th at Cepheid booth #4529.

As part of the program to highlight the need for increased public awareness and education for TB in the U.S., Paul Teutul Jr. and his team at Paul Jr. Designs (www.pauljrdesigns.com), will unveil a brand new creation live during the announcement. Complete details on the program will be disclosed during the event at Cepheid booth #4529.

The live unveil and announcement is open to all show attendees. Those not attending the show in Houston can read the details of the program in an expected simultaneous press release.

###

About Cepheid
Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases.  For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: www.Lung.org.